US Generic Injectables Market Size, Top Companies, Industry Overview, Regional Analysis and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled "𝐔𝐒 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐈𝐧𝐣𝐞𝐜𝐭𝐚𝐛𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐡𝐚𝐫𝐞, 𝐒𝐢𝐳𝐞, 𝐆𝐫𝐨𝐰𝐭𝐡, 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟑-𝟐𝟎𝟐𝟖," The study provides a detailed analysis of the industry, including the US generic injectables market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the US generic injectables market?

The US generic injectables market size reached US$ 18.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.7 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.

What are generic injectables?

Injectables refer to medication delivery tools that are generally used by healthcare professionals for drug administration into the body. They are widely used as a preferred alternative to oral drugs since injectables are quick in delivering drugs selectively to a specific body part while improving the efficacy of the dosage. Generic injectables are bioequivalent of branded injectables that are manufactured after the expiration of the patent of proprietary injectables. The demand for generic injectables is rising in the US since they are identical in terms of dosage, same active ingredients, side effects, route of administration, strength and quality.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐭𝐨 𝐠𝐞𝐭 𝐚𝐧 𝐢𝐝𝐞𝐚 𝐨𝐟 𝐨𝐮𝐫 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐫𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/us-generic-injectables-market/requestsample

US Generic Injectables Market Trends:

The market in the US is primarily driven by the augmenting demand for affordable injectables among the masses. This is supported by the rising prevalence of lifestyle disorders due to the sedentary lifestyles led by individuals. Moreover, the increasing funding activities by major players in extensive research and development (R&D) activities for the development of differentiated generic injectables are further creating a positive market outlook. Along with this, several initiatives undertaken by the US government for providing support to key manufacturers and sellers are positively influencing the market. Additionally, the widespread adoption of advanced technologies in the manufacturing process is acting as a major growth-inducing factor across the country. Other factors, including the easy availability of generic injectables via online and offline pharmacies, patent expiration of several blockbuster injectables and the widespread awareness regarding the cost-efficiency of these injectables, are also favorably impacting the market growth.

Key Market Segmentation:

The report has segmented the US generic injectables market on the basis of therapeutic area, containers, distribution channel, end user and region.

Breakup by Therapeutic Area:

• Oncology
• Anesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular

Breakup by Containers:

• Vials
• Ampoules
• Premix
• Prefilled Syringes

Breakup by Distribution Channel:

• Hospitals
• Retail Pharmacy

𝐀𝐬𝐤 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐟𝐨𝐫 𝟏𝟎% 𝐟𝐫𝐞𝐞 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐞𝐝 𝐫𝐞𝐩𝐨𝐫𝐭:https://www.imarcgroup.com/request?type=report&id=816&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝗦:

IMARC Group

134 N 4th St Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.